Rifaximin‐ciprofloxacin combination therapy is effective in chronic active refractory pouchitis

Abstract

Rifaximin-ciprofloxacin combination therapy is safe and objectively effective in chronic active refractory pouchitis and may salvage a significant percentage of 'at risk pouches'.